MoonLake Immunotherapeutics (MLTX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $424.43M | -11.2% |
| 2024 | $477.93M | -9.2% |
| 2023 | $526.54M | +585.2% |
| 2022 | $76.84M | +693.6% |
| 2021 | $9.68M | -91.7% |
| 2020 | $116.63M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $424.43M | -11.2% |
| 2024 | $477.93M | -9.2% |
| 2023 | $526.54M | +585.2% |
| 2022 | $76.84M | +693.6% |
| 2021 | $9.68M | -91.7% |
| 2020 | $116.63M | — |